Key result
The novel DragonFly transcatheter mitral valve repair system successfully and safely reduced severe degenerative mitral regurgitation to mild at 1-month follow-up in a prohibitive surgical risk patient.
Why the study?
Transcatheter edge-to-edge repair devices have evolved to improve acute MR reduction and procedural durability, prompting the evaluation of the novel DragonFly device in severe DMR.
Does the DragonFly Transcatheter Valve Repair device reduce mitral regurgitation in a high-surgical risk patient with severe degenerative mitral regurgitation?
Comparison
DragonFly Transcatheter Valve Repair device implantation
Design
First-in-man case report
Authors
Loading...
Should not change practice yet; hypothesis-generating for DragonFly in prohibitive-risk degenerative MR.
Case Report (n=1)
No
Does the DragonFly Transcatheter Valve Repair device reduce mitral regurgitation in a high-surgical risk patient with severe degenerative mitral regurgitation?
The novel DragonFly transcatheter mitral valve repair device safely and effectively reduced severe degenerative mitral regurgitation in a prohibitive surgical risk patient.
Liu et al. (2021) conducted a case report in Severe degenerative mitral regurgitation (n=1). DragonFly Transcatheter Valve Repair device was evaluated on Mitral regurgitation reduction. The novel DragonFly transcatheter mitral valve repair system successfully and safely reduced severe degenerative mitral regurgitation to mild at 1-month follow-up in a prohibitive surgical risk patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: